Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human LTB4R Stable Cell Line

    [CAT#: S01YF-0923-PY92]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    GPCR Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Protein
    LTB4R
    Target Family
    Leukotriene Family
    Target Protein Species
    Human
    Host Cell Type
    Caki1;ACHN;CHO-K1;HEK293
    Target Classification
    GPCR Cell Lines
    Target Research Area
    Immunology Research
    Related Diseases
    Dirofilariasis;Cicatricial Entropion
    Gene ID
    Human: 1241
    UniProt ID
    Human: Q15722

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    LTB4R, or Leukotriene B4 receptor, has been identified as a significant player in various diseases. In the context of cancer, LTB4R has been found to regulate the proliferation and apoptosis of renal clear cell carcinoma cells by modulating the AKT/mTOR signaling pathway. Moreover, LTB4R has been recognized as a novel biomarker and independent prognostic indicator for Acute Myeloid Leukemia (AML), shedding light on the crosstalk of leukemogenesis signaling pathways involving tumor immunity and metabolism. Additionally, the expression of LTB4R has been associated with immune infiltrates, suggesting its potential as a prognostic biomarker in pan-cancer.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human LTB4R Stable Cell Line (S01YF-0923-PY92). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Rebecca (Verified Customer)

    Does LTB4R play a significant role in the development of membrane protein cell lines across various expression systems? Mar 02 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The provided articles do not specifically mention the role of LTB4R in the development of membrane protein cell lines. However, it's essential to understand that LTB4R is a specific receptor with potential implications in cellular processes. Mar 02 2021

    chat William (Verified Customer)

    Is LTB4R exclusively an outer membrane protein? Oct 11 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    The provided articles do not categorize LTB4R as an outer membrane protein. It's essential to refer to specific research articles or studies to determine its exact cellular localization. Oct 11 2021

    Published Data

    Fig.1 Silencing LTB4R enhances apoptosis in ccRCC Cells.

    Inducing LTB4R downregulation significantly enhanced apoptotic processes in both Caki1 and ACHN cell lines.

    Ref: Zhang, Xiao, et al. "LTB4R Promotes the Occurrence and Progression of Clear Cell Renal Cell Carcinoma (ccRCC) by Regulating the AKT/mTOR Signaling Pathway." Cells 11.22 (2022): 3606.

    Pubmed: 36429034

    DOI: 10.3390/cells11223606

    Research Highlights

    Lundgren SM, et al. "Signaling dynamics distinguish high- and low-priority neutrophil chemoattractant ." Science signaling, 2023.
    Neutrophils, a type of white blood cell, possess the ability to migrate from blood vessels to sites of infection and injury in response to various signals. These signals may include those produced by pathogens or injuries, as well as long-range inflammatory signals, like LTB4. Despite activating the same G protein family, different chemoattractants can induce unique modes of migration, with high-priority signals causing sustained responses and low-priority signals resulting in transient responses. Through live-cell imaging, it was observed that this difference in signaling dynamics is due to temporal regulation of shared signaling pathways. Specifically, the rapid attenuation of Cdc42 activation in response to LTB4 is dependent on specific phosphorylation sites on the LTB4 receptor, LTB4R, and is not affected by endocytosis. Mutating these sites impairs the ability of neutrophils to prioritize chemoattractants, but does not affect the persistence of migration. Overall, these findings demonstrate the importance of distinct temporal regulation in differentiating between chemoattractants and highlight the role of Ca(2+) and Cdc42 in regulating neutrophil responses.
    Pubmed: 37788324   DOI: 10.1126/scisignal.add1845

    McFarlin BK, et al. "Dry blood spot samples to monitor immune-associated mRNA expression in ." Methods (San Diego, Calif.), 2023.
    In this study, the authors aimed to investigate the feasibility of utilizing their optimized dry blood spot (DBS) methodology to monitor the immunological response to physical stressors in a field setting. This was in contrast to traditional methods which require a laboratory visit and venipuncture for blood collection. The study focused on the effect of Baker's Yeast Beta Glucan supplementation (BYBG; Wellmune; 250 mg/d) on post-exercise mRNA expression. Participants underwent a 90-minute run/walk trial in a hot, humid environment and their venous DBS samples were collected at various time points. Following total RNA extraction and analysis using a 574-plex Human Immunology mRNA panel (Nanostring), the researchers observed that BYBG supplementation was associated with significant changes in the expression of several mRNAs and immune-response pathways. These changes indicated that BYBG may support the immune system, reduce susceptibility to opportunistic infection and improve physical recovery from exercise. The authors conclude that their DBS methodology can be used to investigate the effects of other nutritional, health, or medical interventions in the future.
    Pubmed: 37741562   DOI: 10.1016/j.ymeth.2023.09.006

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare